At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions.
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity.
Headquartered in Denmark, Novo Nordisk employs approximately 43,100
people in 79 countries and markets its products in more than 170
countries.
The Novo Nordisk Way -
who we are, where we want to go and how we work
Each and every employee is responsible for acting in accordance with the Novo Nordisk Way - and to help each other understand what it means in practice.
The Triple Bottom Line -
our way of doing business
We have built our business on the conviction that the formula
for lasting success is to stay focused, think long-term and do
business in a financially, socially and environmentally responsible
way. That is why we manage our business in accordance with the Triple
Bottom Line principle.
The story of Novo Nordisk goes back more than 90 years
It began when August Krogh, a Nobel Prize-winning professor at the University of Copenhagen, decided he wanted to start producing a revolutionary new medical preparation called insulin.
Headquarters
Denmark
International
Affiliates or offices in 79 countries
Workforce
Approximately 43,100 employees
(FTEs
June 2018)
Product areas
General information
More
facts and figures here
Corporate Headquarters
Novo Nordisk A/S
Novo Allé,
2880 Bagsvaerd
Denmark
Where
to reach us
Download financial results, our shareholder magazine, presentations and reports.
